Idaho exchange launches image exchange

The Idaho Health Data Exchange (IHDE) and St. Luke’s Health System (SLHS) announced the launch of Image Exchange viewing capability by eHealthTechnologies.

Image Exchange allows IHDE-authorized physicians, hospitals and clinicians to instantly access, view and collaborate on their patients’ SLHS diagnostic-quality images from the IHDE through a secure, universal web application.

“The IHDE is excited to be able to offer participants this new functionality,” said Scott Carrell, Executive Director, Idaho Health Data Exchange. “It further develops IHDE’s ability to assist healthcare providers by providing them with easy access to images for the treatment of their patients.”

Marc Chasin, MD, system vice president, interim CIO and CMIO of St. Luke’s Health System, said, “By accessing the Idaho Health Data Exchange, clinicians can collaborate on mutual patients thus improving the efficiency and effectiveness in rendering high-quality, low-cost care.”
 
“It allows radiologists to share images performed outside of the system and view them in order to improve the diagnostic quality and changes in the care of the patient,” Chasin added.

As soon as an image has been signed off by a radiologist, it is available and accessible via the IHDE Image Exchange. Benefits include minimizing delays in patient treatment, reducing the need for duplicate exams and limiting unnecessary radiation exposure to patients.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.